ICAM-3 enhances the migratory and invasive potential of human non-small cell lung cancer cells by inducing MMP-2 and MMP-9 via Akt and CREB

International Journal of Oncology

Volumn 36, Issue 1, 2010, Pages 181-192

  Park, Jong Kuk ^a   Park, Seon Ho ^a   So, Kwangsup ^a   Bae, In Hwa ^a   Yoo, Young Do ^b   Um, Hong Duck ^a  

^a Korea Institute of Radiation and Medical Science   (South Korea)

^b Korea University College of Medicine   (South Korea)

Author keywords

Akt; CREB; ICAM 3; Invasion; Migration; MMP

Indexed keywords

BETA ACTIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; GELATINASE A; GELATINASE B; INTERCELLULAR ADHESION MOLECULE 3; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; PROTEIN P53;

ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; METASTASIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; WILD TYPE;

ANTIGENS, CD; ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; CELL ADHESION MOLECULES; CELL LINE, TUMOR; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; HUMANS; LUNG NEOPLASMS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; WOUND HEALING;

EID: 74549132674     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo-00000489     Document Type: Article

References (47)

1. Friedl P and Wolf K: Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer 3: 362-374, 2003.
2. Weber GF: Molecular mechanisms of metastasis. Cancer Lett 270: 181-190, 2008.
3. Gupta GP and Massague J: Cancer metastasis: building a framework. Cell 127: 679-695, 2006.
4. Cheng JC, Chou CH, Kuo ML and Hsieh CY: Radiation-enhanced hepatocellular carcinoma cell invasion with MMP-9 expression through PI3-Kinase/Akt/NF-kB signal transduction pathway. Oncogene 25: 7009-7018, 2006.
5. Chen PN, Hsieh YS, Chiou HL and Chu SC: Silibinin inhibits cell invasion through inactivation of both PI3-Kinase/Akt and MAPK signalling pathways. Chem Biol Interact 156: 141-150, 2005.
6. Kaiser U, Auerbach B and Oldenburg M: The neural cell adhesion molecule NCAM in multiple myeloma. Leuk Lymphoma 20: 389-395, 1996.
7. Watine J and Friedberg B: Laboratory variables and stratification of metastatic colorectal cancer patients: recommendations for therapeutic trials and for clinical practice guidelines. Clin Chim Acta 345: 1-15, 2004.
8. Simmons D, Makgoba MW and Seed B: ICAM, an adhesion ligand of LFA-1, is homologous to the neural cell adhesion molecule NCAM. Nature 331: 624-627, 1998.
9. Springer TA: Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76: 301-314, 1994.
10. Hayflick JS, Kilgannon P and Gallatin WM: The intercellular adhesion molecule (ICAM) family of proteins. New members and novel functions. Immunol Res 17: 313-327, 1998.
11. Toivanen A, Ihanus E, Mattila M, Lutz HU and Gahmberg CG: Importance of molecular studies on major blood groups-intercellular adhesion molecule-4, a blood group antigen involved in multiple cellular interactions. Biochim Biophys Acta 1780: 456-466, 2008.
12. Gahmberg CG, Tian L, Ning L and Nyman-Huttunen H: ICAM-5 - a novel two-facetted adhesion molecule in the mammalian brain. Immunol Lett 117: 131-135, 2008.
13. Figdor CG, van Kooyk Y and Adema GJ: C-type lectin receptors on dendritic cells and Langerhans cells. Nat Rev Immunol 2: 77-84, 2002.
14. Geijtenbeek TBH, Krooshoop DJEB, Bleijs DA, et al: DC-SIGN-ICAM-2 interaction mediates dendritic cell trafficking. Nat Immunol 1: 353-357, 2000
15. Maeda K, Kang SM, Sawada T, et al: Expression of intercellular adhesion molecule-1 and prognosis in colorectal cancer. Oncol Rep 9: 511-514, 2002.
16. Tachimori A, Yamada N, Sakate Y, et al: Up regulation of ICAM-1 gene expression inhibits tumour growth and liver metastasis in colorectal carcinoma. Eur J Cancer 41: 1802-1810, 2005.
17. Johnson JP: Cell adhesion molecules in the development and progression of malignant melanoma. Cancer Metastasis Rev 18: 345-357, 1999.
18. Kobayashi H, Boelte KC and Lin PC: Endothelial cell adhesion molecules and cancer progression. Curr Med Chem 14: 377-386, 2007.
19. Natali PG, Hamby CV, Felding-Habermann B, et al: Clinical significance of alpha(v)beta3 integrin and intercellular adhesion molecule-1 expression in cutaneous malignant melanoma lesions. Cancer Res 57: 1554-1560, 1997.
20. Huang WC, Chan ST, Yang TL, Tzeng CC and Chen CC: Inhibition of ICAM-1 gene expression, monocyte adhesion and cancer cell invasion by targeting IKK complex: molecular and functional study of novel alpha-methylene-gamma- butyrolactone derivatives. Carcinogenesis 25: 1925-1934, 2004.
21. Rosette C, Roth RB, Oeth P, et al: Role of ICAM1 in invasion of human breast cancer cells. Carcinogenesis 26: 943-950, 2005.
22. Montazeri A, Kanitakis J, Zebrine G, Bourchany D, Schmitt D and Claudy A: Expression of ICAM-3/CD50 in normal and diseased skin. Br J Dermatol 133: 377-384, 1995.
23. Molica S, Dattilo A, Mannella A and Levato D: Intercellular adhesion molecules (ICAMs) 2 and 3 are frequently expressed in B cell chronic lymphocytic leukemia. Leukemia 10: 907-908, 1996.
24. Mousa SA: Cell adhesion molecules: potential therapeutic & diagnostic implications. Mol Biotechnol 38: 33-40, 2008.
25. Chung YM, Kim BG, Park CS, et al: Increased expression of ICAM-3 is associated with radiation resistance in cervical cancer. Int J Cancer 117: 194-201, 2005.
26. Kim YG, Kim MJ, Lim JS, Lee MS, Kim JS and Yoo YD: ICAM-3-induced cancer cell proliferation through the PI3K/Akt pathway. Cancer Lett 239: 103-110, 2006.
27. Bae IH, Park MJ, Yoon SH, et al: Bcl-w promotes gastric cancer cell invasion by inducing matrix metalloproteinase-2 expression via phosphoinositide 3-kinase, Akt, and Sp1. Cancer Res 66: 4991-4995, 2006.
28. Park JK, Jung HY, Park SH, et al: Combination of PTEN and gamma-ionizing radiation enhances cell death and G(2)/M arrest through regulation of AKT activity and p21 induction in non-small-cell lung cancer cells. Int J Radiat Oncol Biol Phys 70: 1552-1560, 2008.
29. Weng CJ, Chau CF, Hsieh YS, Yang SF and Yen GC: Lucidenic acid inhibits PMA-induced invasion of human hepatoma cells through inactivating MAPK/ERK signal transduction pathway and reducing binding activities of NF-kappaB and AP-1. Carcinogenesis 29: 147-156, 2008.
30. Yoeli-Lerner M and Toker A: Akt/PKB signaling in cancer: a function in cell motility and invasion. Cell Cycle 5: 603-605, 2006.
31. Chung TW, Lee YC and Kim CH: Hepatitis B viral HBx induces matrix metalloproteinase-9 gene expression through activation of ERK and PI-3K/AKT pathways: involvement of invasive potential. FASEB J 18: 1123-1125, 2004.
32. Kargozaran H, Yuan SY, Breslin JW, et al: A role for endothelial-derived matrix metalloproteinase-2 in breast cancer cell transmigration across the endothelial-basement membrane barrier. Clin Exp Metastasis 24: 495-502, 2007.
33. Levin JI, Chen J, Du M, et al: The discovery of anthranilic acid-based MMP inhibitors. Part 2: SAR of the 5-position and P1(1) groups. Bioorg Med Chem Lett 11: 2189-2192, 2001.
34. Carnero A, Blanco-Aparicio C, Renner O, Link W and Leal JF: The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications. Curr Cancer Drug Targets 8: 187-198, 2008.
35. Du K and Montminy M: CREB is a regulatory target for the protein kinase Akt/PKB. J Biol Chem 273: 32377-32379, 1998.
36. Jean D and Bar-Eli M: Regulation of tumor growth and metastasis of human melanoma by the CREB transcription factor family. Mol Cell Biochem 212: 19-28, 2000.
37. Aucoin R, Reiland J, Roy M and Marchetti D: Dominant-negative CREB inhibits heparanase functionality and melanoma cell invasion. J Cell Biochem 93: 215-223, 2004.
38. Moskovits N, Kalinkovich A, Bar J, Lapidot T and Oren M: p53 attenuates cancer cell migration and invasion through repression of SDF-1/CXCL12 expression in stromal fibroblasts. Cancer Res 66: 10671-10676, 2006.
39. Gadea G, de Toledo M, Anguille C and Roux P: Loss of p53 promotes RhoA-ROCK-dependent cell migration and invasion in 3D matrices. J Cell Biol 178: 23-30, 2007.
40. Tamura M, Gu J, Takino T and Yamada KM: Tumor suppressor PTEN inhibition of cell invasion, migration, and growth: differential involvement of focal adhesion kinase and p130Cas. Cancer Res 59: 442-449, 1999.
41. Basson MD: An intracellular signal pathway that regulates cancer cell adhesion in response to extracellular forces. Cancer Res 68: 2-4, 2008.
42. Xia H, Nho RS, Kahm J, Kleidon J and Henke CA: Focal adhesion kinase is upstream of phosphatidylinositol 3-kinase/Akt in regulating fibroblast survival in response to contraction of type I collagen matrices via a beta 1 integrin viability signaling pathway. J Biol Chem 279: 33024-33034, 2004.
43. Fraser M, Leung B, Jahani-Asl A, Yan X, Thompson WE and Tsang BK: Chemoresistance in human ovarian cancer: the role of apoptotic regulators. Reprod Biol Endocrinol 1: 66, 2003.
44. Carlson M, Longaker J and Thompson JS: Modulation of FAK, Akt, and p53 by stress release of the fibroblast-populated collagen matrix1, 2. J Surg Res 120: 171-177, 2004.
45. Park C-M, Park M-J, Kwak H-J, et al: Ionizing radiation enhances matrix metalloproteinase-2 secretion and invasion of glioma cells through Src/epidermal growth factor receptor-mediated p38/Akt and phosphatidylinositol 3-kinase/Akt signaling pathways. Cancer Res 66: 8511-8519, 2006.
46. Beinke C, van Beuningen D and Cordes N: Ionizing radiation modulates expression and tyrosine phosphorylation of the focal adhesion-associated proteins focal adhesion kinase (FAK) and its substrates p130cas and paxillin in A549 human lung carcinoma cells in vitro. Int J Radiat Biol Phys 79: 721-731, 2003.
47. Hideshima T, Chauhan D, Podar K, Schlossman RL, Richardson P and Anderson KC: Novel therapies targeting the myeloma cell and its bone marrow microenvironment. Semin Oncol 28: 607-612, 2001.